{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "BLOOD AND BLOOD FORMING ORGANS" , "@language" : "en" } ,        { "@value" : "Krev a krvetvorn\u00E9 org\u00E1ny" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B03",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antianemika" , "@language" : "cs" } ,        { "@value" : "ANTIANEMIC PREPARATIONS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B03" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B03X",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "OTHER ANTIANEMIC PREPARATIONS" , "@language" : "en" } ,        { "@value" : "Jin\u00E1 antianemika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B03X" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B03XA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Jin\u00E1 antianemika" , "@language" : "cs" } ,        { "@value" : "Other antianemic preparations" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B03XA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/B03XA01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/B" ,        "http://linked.opendata.cz/resource/ATC/B03" ,        "http://linked.opendata.cz/resource/ATC/B03XA" ,        "http://linked.opendata.cz/resource/ATC/B03X" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Erythropoietin" , "@language" : "en" } ,        { "@value" : "Erytropoetin" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "B03XA01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001616",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hypertenze" , "@language" : "cs" } ,        { "@value" : "Hypertension" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028770",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Epoetin alfa" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000001616" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/EPREX-1000-IU-0-1ML",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028770" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EPREX 1000 IU/0,1ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B03XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014974" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014975" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014977" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014970" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014971" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014973" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014970",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EPREX 1000 IU/0,1ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B03XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIANAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132234_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "6X0.4ML ST" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10KU/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba symptomatick\u00E9 anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm (CRF) u dosp\u011Bl\u00FDch a pediatrick\u00FDch pacient\u016F\nL\u00E9\u010Dba anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm u pediatrick\u00FDch a dosp\u011Bl\u00FDch hemodialyzovan\u00FDch pacient\u016F a dosp\u011Bl\u00FDch pacient\u016F dialyzovan\u00FDch peritone\u00E1ln\u011B.\nL\u00E9\u010Dba t\u011B\u017Ek\u00E9 anemie ren\u00E1ln\u00EDho p\u016Fvodu s\u00A0vyj\u00E1d\u0159en\u00FDmi klinick\u00FDmi p\u0159\u00EDznaky u\u00A0dosp\u011Bl\u00FDch pacient\u016F s\u00A0ren\u00E1ln\u00ED insuficienc\u00ED, kte\u0159\u00ED nejsou dosud dialyzov\u00E1ni.\nL\u00E9\u010Dba anemie a sn\u00ED\u017Een\u00ED pot\u0159eby transfuze dosp\u011Bl\u00FDch pacient\u016F podstupuj\u00EDc\u00EDch chemoterapii solidn\u00EDch tumor\u016F, malign\u00EDho lymfomu nebo mnoho\u010Detn\u00E9ho myelomu, a v\u00A0p\u0159\u00EDpad\u011B rizika transfuze vypl\u00FDvaj\u00EDc\u00ED z\u00A0celkov\u00E9ho stavu pacienta (nap\u0159. stavu kardiovaskul\u00E1rn\u00EDho syst\u00E9mu, anemie ji\u017E p\u0159\u00EDtomn\u00E9 p\u0159ed zah\u00E1jen\u00EDm chemoterapie).\nZv\u00FD\u0161en\u00ED v\u00FDt\u011B\u017Eku autologn\u00ED krve u dosp\u011Bl\u00FDch pacient\u016F v\u00A0programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a ke sn\u00ED\u017Een\u00ED rizika alogenn\u00EDch krevn\u00EDch transfuz\u00ED. \nPou\u017Eit\u00ED v\u00A0t\u00E9to indikaci mus\u00ED b\u00FDt posouzeno s\u00A0ohledem na popisovan\u00E1 rizika tromboembolick\u00FDch p\u0159\u00EDhod. L\u00E9\u010Dba je vhodn\u00E1 pouze u st\u0159edn\u011B z\u00E1va\u017En\u00E9 anemie (Hb 10\u201113\u00A0g/dl \uFFFD[6,2-8,1 mmol/l], bez deficitu \u017Eeleza) v\u00A0p\u0159\u00EDpad\u011B, \u017Ee nelze vyu\u017E\u00EDt postup\u016F pro \u00FAsporu krve nebo tyto postupy neposta\u010Duj\u00ED p\u0159i pl\u00E1novan\u00E9m velk\u00E9m chirurgick\u00E9m v\u00FDkonu n\u00E1ro\u010Dn\u00E9m na pot\u0159ebu velk\u00E9ho objemu krve (4 nebo v\u00EDce krevn\u00EDch jednotek u \u017Een a 5 nebo v\u00EDce u mu\u017E\u016F).\nSn\u00ED\u017Een\u00ED po\u010Dtu alogenn\u00EDch krevn\u00EDch transfuz\u00ED u dosp\u011Bl\u00FDch pacient\u016F bez deficitu \u017Eeleza, p\u0159edev\u0161\u00EDm u pl\u00E1novan\u00FDch velk\u00FDch ortopedick\u00FDch operac\u00ED s\u00A0vysok\u00FDm rizikem komplikac\u00ED spojen\u00FDch s\u00A0transfuz\u00ED. Pou\u017Eit\u00ED by m\u011Blo b\u00FDt vymezeno pro pacienty se\u00A0st\u0159edn\u011B z\u00E1va\u017Enou anemi\u00ED (Hb 10\u201113\u00A0g/dl), kte\u0159\u00ED nejsou za\u0159azeni do programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a p\u0159i o\u010Dek\u00E1van\u00E9 krevn\u00ED ztr\u00E1t\u011B st\u0159edn\u00EDho rozsahu (900-1800 ml).\nP\u0159i pou\u017Eit\u00ED v\u00A0perichirurgii je zapot\u0159eb\u00ED v\u017Edy dodr\u017Eovat z\u00E1sady spr\u00E1vn\u00E9ho postupu zach\u00E1zen\u00ED s\u00A0krv\u00ED a krevn\u00EDmi deriv\u00E1ty.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 7699.2001953125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 4919.7001953125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 6X0.4ML/4KU" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014971",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EPREX 1000 IU/0,1ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B03XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIANAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132234_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "6X1ML ST" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10KU/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba symptomatick\u00E9 anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm (CRF) u dosp\u011Bl\u00FDch a pediatrick\u00FDch pacient\u016F\nL\u00E9\u010Dba anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm u pediatrick\u00FDch a dosp\u011Bl\u00FDch hemodialyzovan\u00FDch pacient\u016F a dosp\u011Bl\u00FDch pacient\u016F dialyzovan\u00FDch peritone\u00E1ln\u011B.\nL\u00E9\u010Dba t\u011B\u017Ek\u00E9 anemie ren\u00E1ln\u00EDho p\u016Fvodu s\u00A0vyj\u00E1d\u0159en\u00FDmi klinick\u00FDmi p\u0159\u00EDznaky u\u00A0dosp\u011Bl\u00FDch pacient\u016F s\u00A0ren\u00E1ln\u00ED insuficienc\u00ED, kte\u0159\u00ED nejsou dosud dialyzov\u00E1ni.\nL\u00E9\u010Dba anemie a sn\u00ED\u017Een\u00ED pot\u0159eby transfuze dosp\u011Bl\u00FDch pacient\u016F podstupuj\u00EDc\u00EDch chemoterapii solidn\u00EDch tumor\u016F, malign\u00EDho lymfomu nebo mnoho\u010Detn\u00E9ho myelomu, a v\u00A0p\u0159\u00EDpad\u011B rizika transfuze vypl\u00FDvaj\u00EDc\u00ED z\u00A0celkov\u00E9ho stavu pacienta (nap\u0159. stavu kardiovaskul\u00E1rn\u00EDho syst\u00E9mu, anemie ji\u017E p\u0159\u00EDtomn\u00E9 p\u0159ed zah\u00E1jen\u00EDm chemoterapie).\nZv\u00FD\u0161en\u00ED v\u00FDt\u011B\u017Eku autologn\u00ED krve u dosp\u011Bl\u00FDch pacient\u016F v\u00A0programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a ke sn\u00ED\u017Een\u00ED rizika alogenn\u00EDch krevn\u00EDch transfuz\u00ED. \nPou\u017Eit\u00ED v\u00A0t\u00E9to indikaci mus\u00ED b\u00FDt posouzeno s\u00A0ohledem na popisovan\u00E1 rizika tromboembolick\u00FDch p\u0159\u00EDhod. L\u00E9\u010Dba je vhodn\u00E1 pouze u st\u0159edn\u011B z\u00E1va\u017En\u00E9 anemie (Hb 10\u201113\u00A0g/dl \uFFFD[6,2-8,1 mmol/l], bez deficitu \u017Eeleza) v\u00A0p\u0159\u00EDpad\u011B, \u017Ee nelze vyu\u017E\u00EDt postup\u016F pro \u00FAsporu krve nebo tyto postupy neposta\u010Duj\u00ED p\u0159i pl\u00E1novan\u00E9m velk\u00E9m chirurgick\u00E9m v\u00FDkonu n\u00E1ro\u010Dn\u00E9m na pot\u0159ebu velk\u00E9ho objemu krve (4 nebo v\u00EDce krevn\u00EDch jednotek u \u017Een a 5 nebo v\u00EDce u mu\u017E\u016F).\nSn\u00ED\u017Een\u00ED po\u010Dtu alogenn\u00EDch krevn\u00EDch transfuz\u00ED u dosp\u011Bl\u00FDch pacient\u016F bez deficitu \u017Eeleza, p\u0159edev\u0161\u00EDm u pl\u00E1novan\u00FDch velk\u00FDch ortopedick\u00FDch operac\u00ED s\u00A0vysok\u00FDm rizikem komplikac\u00ED spojen\u00FDch s\u00A0transfuz\u00ED. Pou\u017Eit\u00ED by m\u011Blo b\u00FDt vymezeno pro pacienty se\u00A0st\u0159edn\u011B z\u00E1va\u017Enou anemi\u00ED (Hb 10\u201113\u00A0g/dl), kte\u0159\u00ED nejsou za\u0159azeni do programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a p\u0159i o\u010Dek\u00E1van\u00E9 krevn\u00ED ztr\u00E1t\u011B st\u0159edn\u00EDho rozsahu (900-1800 ml).\nP\u0159i pou\u017Eit\u00ED v\u00A0perichirurgii je zapot\u0159eb\u00ED v\u017Edy dodr\u017Eovat z\u00E1sady spr\u00E1vn\u00E9ho postupu zach\u00E1zen\u00ED s\u00A0krv\u00ED a krevn\u00EDmi deriv\u00E1ty.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasBreakMarketingDate" : [ { "@value" : "2012-04-30" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 17602.109375 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 12299.25 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 6X1ML/10KU" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014973",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EPREX 1000 IU/0,1ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B03XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIANAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132234_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "6X0.3ML ST" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10KU/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba symptomatick\u00E9 anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm (CRF) u dosp\u011Bl\u00FDch a pediatrick\u00FDch pacient\u016F\nL\u00E9\u010Dba anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm u pediatrick\u00FDch a dosp\u011Bl\u00FDch hemodialyzovan\u00FDch pacient\u016F a dosp\u011Bl\u00FDch pacient\u016F dialyzovan\u00FDch peritone\u00E1ln\u011B.\nL\u00E9\u010Dba t\u011B\u017Ek\u00E9 anemie ren\u00E1ln\u00EDho p\u016Fvodu s\u00A0vyj\u00E1d\u0159en\u00FDmi klinick\u00FDmi p\u0159\u00EDznaky u\u00A0dosp\u011Bl\u00FDch pacient\u016F s\u00A0ren\u00E1ln\u00ED insuficienc\u00ED, kte\u0159\u00ED nejsou dosud dialyzov\u00E1ni.\nL\u00E9\u010Dba anemie a sn\u00ED\u017Een\u00ED pot\u0159eby transfuze dosp\u011Bl\u00FDch pacient\u016F podstupuj\u00EDc\u00EDch chemoterapii solidn\u00EDch tumor\u016F, malign\u00EDho lymfomu nebo mnoho\u010Detn\u00E9ho myelomu, a v\u00A0p\u0159\u00EDpad\u011B rizika transfuze vypl\u00FDvaj\u00EDc\u00ED z\u00A0celkov\u00E9ho stavu pacienta (nap\u0159. stavu kardiovaskul\u00E1rn\u00EDho syst\u00E9mu, anemie ji\u017E p\u0159\u00EDtomn\u00E9 p\u0159ed zah\u00E1jen\u00EDm chemoterapie).\nZv\u00FD\u0161en\u00ED v\u00FDt\u011B\u017Eku autologn\u00ED krve u dosp\u011Bl\u00FDch pacient\u016F v\u00A0programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a ke sn\u00ED\u017Een\u00ED rizika alogenn\u00EDch krevn\u00EDch transfuz\u00ED. \nPou\u017Eit\u00ED v\u00A0t\u00E9to indikaci mus\u00ED b\u00FDt posouzeno s\u00A0ohledem na popisovan\u00E1 rizika tromboembolick\u00FDch p\u0159\u00EDhod. L\u00E9\u010Dba je vhodn\u00E1 pouze u st\u0159edn\u011B z\u00E1va\u017En\u00E9 anemie (Hb 10\u201113\u00A0g/dl \uFFFD[6,2-8,1 mmol/l], bez deficitu \u017Eeleza) v\u00A0p\u0159\u00EDpad\u011B, \u017Ee nelze vyu\u017E\u00EDt postup\u016F pro \u00FAsporu krve nebo tyto postupy neposta\u010Duj\u00ED p\u0159i pl\u00E1novan\u00E9m velk\u00E9m chirurgick\u00E9m v\u00FDkonu n\u00E1ro\u010Dn\u00E9m na pot\u0159ebu velk\u00E9ho objemu krve (4 nebo v\u00EDce krevn\u00EDch jednotek u \u017Een a 5 nebo v\u00EDce u mu\u017E\u016F).\nSn\u00ED\u017Een\u00ED po\u010Dtu alogenn\u00EDch krevn\u00EDch transfuz\u00ED u dosp\u011Bl\u00FDch pacient\u016F bez deficitu \u017Eeleza, p\u0159edev\u0161\u00EDm u pl\u00E1novan\u00FDch velk\u00FDch ortopedick\u00FDch operac\u00ED s\u00A0vysok\u00FDm rizikem komplikac\u00ED spojen\u00FDch s\u00A0transfuz\u00ED. Pou\u017Eit\u00ED by m\u011Blo b\u00FDt vymezeno pro pacienty se\u00A0st\u0159edn\u011B z\u00E1va\u017Enou anemi\u00ED (Hb 10\u201113\u00A0g/dl), kte\u0159\u00ED nejsou za\u0159azeni do programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a p\u0159i o\u010Dek\u00E1van\u00E9 krevn\u00ED ztr\u00E1t\u011B st\u0159edn\u00EDho rozsahu (900-1800 ml).\nP\u0159i pou\u017Eit\u00ED v\u00A0perichirurgii je zapot\u0159eb\u00ED v\u017Edy dodr\u017Eovat z\u00E1sady spr\u00E1vn\u00E9ho postupu zach\u00E1zen\u00ED s\u00A0krv\u00ED a krevn\u00EDmi deriv\u00E1ty.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 5498.75 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 3689.780029296875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 6X0.3ML/3KU" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014974",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EPREX 1000 IU/0,1ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B03XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIANAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132234_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "6X0.5ML ST" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10KU/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba symptomatick\u00E9 anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm (CRF) u dosp\u011Bl\u00FDch a pediatrick\u00FDch pacient\u016F\nL\u00E9\u010Dba anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm u pediatrick\u00FDch a dosp\u011Bl\u00FDch hemodialyzovan\u00FDch pacient\u016F a dosp\u011Bl\u00FDch pacient\u016F dialyzovan\u00FDch peritone\u00E1ln\u011B.\nL\u00E9\u010Dba t\u011B\u017Ek\u00E9 anemie ren\u00E1ln\u00EDho p\u016Fvodu s\u00A0vyj\u00E1d\u0159en\u00FDmi klinick\u00FDmi p\u0159\u00EDznaky u\u00A0dosp\u011Bl\u00FDch pacient\u016F s\u00A0ren\u00E1ln\u00ED insuficienc\u00ED, kte\u0159\u00ED nejsou dosud dialyzov\u00E1ni.\nL\u00E9\u010Dba anemie a sn\u00ED\u017Een\u00ED pot\u0159eby transfuze dosp\u011Bl\u00FDch pacient\u016F podstupuj\u00EDc\u00EDch chemoterapii solidn\u00EDch tumor\u016F, malign\u00EDho lymfomu nebo mnoho\u010Detn\u00E9ho myelomu, a v\u00A0p\u0159\u00EDpad\u011B rizika transfuze vypl\u00FDvaj\u00EDc\u00ED z\u00A0celkov\u00E9ho stavu pacienta (nap\u0159. stavu kardiovaskul\u00E1rn\u00EDho syst\u00E9mu, anemie ji\u017E p\u0159\u00EDtomn\u00E9 p\u0159ed zah\u00E1jen\u00EDm chemoterapie).\nZv\u00FD\u0161en\u00ED v\u00FDt\u011B\u017Eku autologn\u00ED krve u dosp\u011Bl\u00FDch pacient\u016F v\u00A0programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a ke sn\u00ED\u017Een\u00ED rizika alogenn\u00EDch krevn\u00EDch transfuz\u00ED. \nPou\u017Eit\u00ED v\u00A0t\u00E9to indikaci mus\u00ED b\u00FDt posouzeno s\u00A0ohledem na popisovan\u00E1 rizika tromboembolick\u00FDch p\u0159\u00EDhod. L\u00E9\u010Dba je vhodn\u00E1 pouze u st\u0159edn\u011B z\u00E1va\u017En\u00E9 anemie (Hb 10\u201113\u00A0g/dl \uFFFD[6,2-8,1 mmol/l], bez deficitu \u017Eeleza) v\u00A0p\u0159\u00EDpad\u011B, \u017Ee nelze vyu\u017E\u00EDt postup\u016F pro \u00FAsporu krve nebo tyto postupy neposta\u010Duj\u00ED p\u0159i pl\u00E1novan\u00E9m velk\u00E9m chirurgick\u00E9m v\u00FDkonu n\u00E1ro\u010Dn\u00E9m na pot\u0159ebu velk\u00E9ho objemu krve (4 nebo v\u00EDce krevn\u00EDch jednotek u \u017Een a 5 nebo v\u00EDce u mu\u017E\u016F).\nSn\u00ED\u017Een\u00ED po\u010Dtu alogenn\u00EDch krevn\u00EDch transfuz\u00ED u dosp\u011Bl\u00FDch pacient\u016F bez deficitu \u017Eeleza, p\u0159edev\u0161\u00EDm u pl\u00E1novan\u00FDch velk\u00FDch ortopedick\u00FDch operac\u00ED s\u00A0vysok\u00FDm rizikem komplikac\u00ED spojen\u00FDch s\u00A0transfuz\u00ED. Pou\u017Eit\u00ED by m\u011Blo b\u00FDt vymezeno pro pacienty se\u00A0st\u0159edn\u011B z\u00E1va\u017Enou anemi\u00ED (Hb 10\u201113\u00A0g/dl), kte\u0159\u00ED nejsou za\u0159azeni do programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a p\u0159i o\u010Dek\u00E1van\u00E9 krevn\u00ED ztr\u00E1t\u011B st\u0159edn\u00EDho rozsahu (900-1800 ml).\nP\u0159i pou\u017Eit\u00ED v\u00A0perichirurgii je zapot\u0159eb\u00ED v\u017Edy dodr\u017Eovat z\u00E1sady spr\u00E1vn\u00E9ho postupu zach\u00E1zen\u00ED s\u00A0krv\u00ED a krevn\u00EDmi deriv\u00E1ty.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 6X0.5ML/5KU" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014975",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EPREX 1000 IU/0,1ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B03XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIANAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132234_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "6X0.6ML ST" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10KU/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba symptomatick\u00E9 anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm (CRF) u dosp\u011Bl\u00FDch a pediatrick\u00FDch pacient\u016F\nL\u00E9\u010Dba anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm u pediatrick\u00FDch a dosp\u011Bl\u00FDch hemodialyzovan\u00FDch pacient\u016F a dosp\u011Bl\u00FDch pacient\u016F dialyzovan\u00FDch peritone\u00E1ln\u011B.\nL\u00E9\u010Dba t\u011B\u017Ek\u00E9 anemie ren\u00E1ln\u00EDho p\u016Fvodu s\u00A0vyj\u00E1d\u0159en\u00FDmi klinick\u00FDmi p\u0159\u00EDznaky u\u00A0dosp\u011Bl\u00FDch pacient\u016F s\u00A0ren\u00E1ln\u00ED insuficienc\u00ED, kte\u0159\u00ED nejsou dosud dialyzov\u00E1ni.\nL\u00E9\u010Dba anemie a sn\u00ED\u017Een\u00ED pot\u0159eby transfuze dosp\u011Bl\u00FDch pacient\u016F podstupuj\u00EDc\u00EDch chemoterapii solidn\u00EDch tumor\u016F, malign\u00EDho lymfomu nebo mnoho\u010Detn\u00E9ho myelomu, a v\u00A0p\u0159\u00EDpad\u011B rizika transfuze vypl\u00FDvaj\u00EDc\u00ED z\u00A0celkov\u00E9ho stavu pacienta (nap\u0159. stavu kardiovaskul\u00E1rn\u00EDho syst\u00E9mu, anemie ji\u017E p\u0159\u00EDtomn\u00E9 p\u0159ed zah\u00E1jen\u00EDm chemoterapie).\nZv\u00FD\u0161en\u00ED v\u00FDt\u011B\u017Eku autologn\u00ED krve u dosp\u011Bl\u00FDch pacient\u016F v\u00A0programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a ke sn\u00ED\u017Een\u00ED rizika alogenn\u00EDch krevn\u00EDch transfuz\u00ED. \nPou\u017Eit\u00ED v\u00A0t\u00E9to indikaci mus\u00ED b\u00FDt posouzeno s\u00A0ohledem na popisovan\u00E1 rizika tromboembolick\u00FDch p\u0159\u00EDhod. L\u00E9\u010Dba je vhodn\u00E1 pouze u st\u0159edn\u011B z\u00E1va\u017En\u00E9 anemie (Hb 10\u201113\u00A0g/dl \uFFFD[6,2-8,1 mmol/l], bez deficitu \u017Eeleza) v\u00A0p\u0159\u00EDpad\u011B, \u017Ee nelze vyu\u017E\u00EDt postup\u016F pro \u00FAsporu krve nebo tyto postupy neposta\u010Duj\u00ED p\u0159i pl\u00E1novan\u00E9m velk\u00E9m chirurgick\u00E9m v\u00FDkonu n\u00E1ro\u010Dn\u00E9m na pot\u0159ebu velk\u00E9ho objemu krve (4 nebo v\u00EDce krevn\u00EDch jednotek u \u017Een a 5 nebo v\u00EDce u mu\u017E\u016F).\nSn\u00ED\u017Een\u00ED po\u010Dtu alogenn\u00EDch krevn\u00EDch transfuz\u00ED u dosp\u011Bl\u00FDch pacient\u016F bez deficitu \u017Eeleza, p\u0159edev\u0161\u00EDm u pl\u00E1novan\u00FDch velk\u00FDch ortopedick\u00FDch operac\u00ED s\u00A0vysok\u00FDm rizikem komplikac\u00ED spojen\u00FDch s\u00A0transfuz\u00ED. Pou\u017Eit\u00ED by m\u011Blo b\u00FDt vymezeno pro pacienty se\u00A0st\u0159edn\u011B z\u00E1va\u017Enou anemi\u00ED (Hb 10\u201113\u00A0g/dl), kte\u0159\u00ED nejsou za\u0159azeni do programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a p\u0159i o\u010Dek\u00E1van\u00E9 krevn\u00ED ztr\u00E1t\u011B st\u0159edn\u00EDho rozsahu (900-1800 ml).\nP\u0159i pou\u017Eit\u00ED v\u00A0perichirurgii je zapot\u0159eb\u00ED v\u017Edy dodr\u017Eovat z\u00E1sady spr\u00E1vn\u00E9ho postupu zach\u00E1zen\u00ED s\u00A0krv\u00ED a krevn\u00EDmi deriv\u00E1ty.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 10408.8603515625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 7379.5498046875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 6X0.6ML/6KU" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014977",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "EPREX 1000 IU/0,1ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/B03XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIANAEMICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC132234_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "6X0.8ML ST" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "10KU/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba symptomatick\u00E9 anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm (CRF) u dosp\u011Bl\u00FDch a pediatrick\u00FDch pacient\u016F\nL\u00E9\u010Dba anemie spojen\u00E9 s\u00A0chronick\u00FDm ren\u00E1ln\u00EDm selh\u00E1n\u00EDm u pediatrick\u00FDch a dosp\u011Bl\u00FDch hemodialyzovan\u00FDch pacient\u016F a dosp\u011Bl\u00FDch pacient\u016F dialyzovan\u00FDch peritone\u00E1ln\u011B.\nL\u00E9\u010Dba t\u011B\u017Ek\u00E9 anemie ren\u00E1ln\u00EDho p\u016Fvodu s\u00A0vyj\u00E1d\u0159en\u00FDmi klinick\u00FDmi p\u0159\u00EDznaky u\u00A0dosp\u011Bl\u00FDch pacient\u016F s\u00A0ren\u00E1ln\u00ED insuficienc\u00ED, kte\u0159\u00ED nejsou dosud dialyzov\u00E1ni.\nL\u00E9\u010Dba anemie a sn\u00ED\u017Een\u00ED pot\u0159eby transfuze dosp\u011Bl\u00FDch pacient\u016F podstupuj\u00EDc\u00EDch chemoterapii solidn\u00EDch tumor\u016F, malign\u00EDho lymfomu nebo mnoho\u010Detn\u00E9ho myelomu, a v\u00A0p\u0159\u00EDpad\u011B rizika transfuze vypl\u00FDvaj\u00EDc\u00ED z\u00A0celkov\u00E9ho stavu pacienta (nap\u0159. stavu kardiovaskul\u00E1rn\u00EDho syst\u00E9mu, anemie ji\u017E p\u0159\u00EDtomn\u00E9 p\u0159ed zah\u00E1jen\u00EDm chemoterapie).\nZv\u00FD\u0161en\u00ED v\u00FDt\u011B\u017Eku autologn\u00ED krve u dosp\u011Bl\u00FDch pacient\u016F v\u00A0programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a ke sn\u00ED\u017Een\u00ED rizika alogenn\u00EDch krevn\u00EDch transfuz\u00ED. \nPou\u017Eit\u00ED v\u00A0t\u00E9to indikaci mus\u00ED b\u00FDt posouzeno s\u00A0ohledem na popisovan\u00E1 rizika tromboembolick\u00FDch p\u0159\u00EDhod. L\u00E9\u010Dba je vhodn\u00E1 pouze u st\u0159edn\u011B z\u00E1va\u017En\u00E9 anemie (Hb 10\u201113\u00A0g/dl \uFFFD[6,2-8,1 mmol/l], bez deficitu \u017Eeleza) v\u00A0p\u0159\u00EDpad\u011B, \u017Ee nelze vyu\u017E\u00EDt postup\u016F pro \u00FAsporu krve nebo tyto postupy neposta\u010Duj\u00ED p\u0159i pl\u00E1novan\u00E9m velk\u00E9m chirurgick\u00E9m v\u00FDkonu n\u00E1ro\u010Dn\u00E9m na pot\u0159ebu velk\u00E9ho objemu krve (4 nebo v\u00EDce krevn\u00EDch jednotek u \u017Een a 5 nebo v\u00EDce u mu\u017E\u016F).\nSn\u00ED\u017Een\u00ED po\u010Dtu alogenn\u00EDch krevn\u00EDch transfuz\u00ED u dosp\u011Bl\u00FDch pacient\u016F bez deficitu \u017Eeleza, p\u0159edev\u0161\u00EDm u pl\u00E1novan\u00FDch velk\u00FDch ortopedick\u00FDch operac\u00ED s\u00A0vysok\u00FDm rizikem komplikac\u00ED spojen\u00FDch s\u00A0transfuz\u00ED. Pou\u017Eit\u00ED by m\u011Blo b\u00FDt vymezeno pro pacienty se\u00A0st\u0159edn\u011B z\u00E1va\u017Enou anemi\u00ED (Hb 10\u201113\u00A0g/dl), kte\u0159\u00ED nejsou za\u0159azeni do programu p\u0159edopera\u010Dn\u00EDho autologn\u00EDho odb\u011Bru a p\u0159i o\u010Dek\u00E1van\u00E9 krevn\u00ED ztr\u00E1t\u011B st\u0159edn\u00EDho rozsahu (900-1800 ml).\nP\u0159i pou\u017Eit\u00ED v\u00A0perichirurgii je zapot\u0159eb\u00ED v\u017Edy dodr\u017Eovat z\u00E1sady spr\u00E1vn\u00E9ho postupu zach\u00E1zen\u00ED s\u00A0krv\u00ED a krevn\u00EDmi deriv\u00E1ty.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 6X0.8ML/8KU" , "@language" : "cs" } ] }] }